Results 81 to 90 of about 2,073 (215)

Further Practical Guidance on Adjusting Time‐To‐Event Outcomes for Treatment Switching

Pharmaceutical Statistics, Volume 24, Issue 4, July/August 2025.
ABSTRACT The objective of this article is to bring together the key current information on practical considerations when conducting statistical analyses adjusting long‐term outcomes for treatment switching, combining it with learnings from our own experience, thus providing a useful reference tool for analysts.
Claire Watkins, Eva Kleine, Miguel Miranda, Emmanuel Bourmaud, Orlando Doehring   +4 more
wiley   +1 more source

Cabazitaxel [PDF]

Der Bericht zur Therapie mit Cabazitaxel bei Männern mit kastrationsrefraktärem Prostatakarzinom nach Docetaxel-Therapie ist die zweite Nutzenbewertung eines onkologischen Medikamentes nach dem AMNOG.
Honecker, Friedemann, Wörmann, Bernhard, Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie, Deutschland. Gemeinsamer Bundesausschuss, Bokemeyer, Carsten   +4 more
core   +3 more sources

Identifying nurse staffing research in Medline: development and testing of empirically derived search strategies with the PubMed interface [PDF]

, 2010
Background: The identification of health services research in databases such as PubMed/Medline is a cumbersome task. This task becomes even more difficult if the field of interest involves the use of diverse methods and data sources, as is the case with ...
Dunton, Nancy E., Simon Michael, Hausner Elke, Hausner, Elke, Dunton Nancy E, Klaus, Susan F., Simon, Michael, Elke Hausner, Susan F Klaus, Nancy E Dunton, Klaus Susan F, Michael Simon   +11 more
core   +1 more source

Systematic reviews of health economic evaluations: a protocol for a systematic review of characteristics and methods applied

Systematic Reviews, 2017
Background The number of systematic reviews of economic evaluations is steadily increasing. This is probably related to the continuing pressure on health budgets worldwide which makes an efficient resource allocation increasingly crucial.
Miriam Luhnen, Barbara Prediger, Edmund A. M. Neugebauer, Tim Mathes   +3 more
doaj   +1 more source

Reply to: Letter to the Editor on the Paper: “Do the Clinical Practice Guidelines for Pediatric Dentistry Meet the Quality Standards?”

International Journal of Paediatric Dentistry, Volume 35, Issue 6, Page 1023-1025, November 2025.
Rokaia Ahmed Elagami, Caroline Marino Laux, Tamara Kerber Tedesco, Thais Gimenez Cóvos, Mariana Minatel Braga, Fausto Medeiros Mendes, Maximiliano Sérgio Cenci, Daniela Prócida Raggio   +7 more
wiley   +1 more source

Stellungnahmen der wissenschaftlichen Fachgesellschaften - Zwischenbilanz und weitere Entwicklungen [PDF]

, 2013
Rund anderthalb Jahre nach In-Kraft-Treten des Versorgungsstrukturgesetzes zogen die wissenschaftlichen medizinischen Fachgesellschaften (FG) am 25. Juni 2013 anlässlich der zweiten Arbeitstagung zu Stellungnahmen eine Zwischenbilanz.
Selbmann, HK, Kopp, I, Müller, W, Nothacker, M   +3 more
core   +1 more source

Early benefit assessment (EBA) in Germany: analysing decisions 18 months after introducing the new AMNOG legislation [PDF]

, 2014
Since the introduction of the German health care reform in January 2011, an early benefit assessment (EBA) is required for all new medicines. Pharmaceutical manufacturers have to submit a benefit dossier for evaluation by the Institute for Quality and ...
Schulenburg, Johann-Matthias Graf von der, Schwartz, Friedrich Wilhelm, Dintsios, Charalabos-Markos, Ruof, Joerg   +3 more
core   +2 more sources

Epidemiology and reporting characteristics of overviews of reviews of healthcare interventions published 2012–2016: protocol for a systematic review

Systematic Reviews, 2017
Background Overviews of systematic reviews (overviews) attempt to systematically retrieve and summarize the results of multiple systematic reviews (SRs) for a given condition or public health problem.
Dawid Pieper, Michelle Pollock, Ricardo M. Fernandes, Roland Brian Büchter, Lisa Hartling   +4 more
doaj   +1 more source

„Wir müssen gemessene Werte stärker mit PRO verknüpfen”

Monitor Versorgungsforschung
Die unterschiedliche Nutzenbewertung von Pembrolizumab („Keytruda”) durch das IQWiG und die ESMO, auf die Institutsleiter Dr. med. Thomas Kaiser im „Monitor-Versorgungsforschung”-Titelinterview der Ausgabe 02/25 einging, wirft grundlegende Fragen zur ...
Prof. Dr. Reinhold Roski, Peter Stegmaier, Prof. Dr. med. Bernhard Wörmann   +2 more
doaj   +1 more source

OP77 Identifying Topics For Health Technology Assessment: The German “ThemenCheck Medizin” [PDF]

, 2017
INTRODUCTION:Clinicians, epidemiologists, economists and other non-medical professions are involved in the production of Health Technology Assessment (HTA) reports.
Ulrich Siering, Sarah Thys, Lutz Altenhofen, Claudia Mischke   +3 more
core   +1 more source